Holly Kordasiewicz, PhDSVP Research, Franchise Leader Neurology R&D at Ionis PharmaceuticalsSpeaker
Profile
Dr. Holly Kordasiewicz is Senior Vice President of Neurology Research at Ionis Pharmaceuticals, a company that specializes in RNA therapeutics. Dr. Kordasiewicz leads a team focused on identifying antisense oligonucleotide therapeutics for currently untreatable neurological diseases, including drugs now in clinical trials for ALS, Alzheimer’s disease, and Parkinson’s disease. Dr. Kordasiewicz joined Ionis 11 years ago after completing her post-doctoral fellowship in the laboratory of Dr. Don Cleveland at the University of California at San Diego where she worked to develop therapies for Huntington’s disease. Dr. Kordasiewicz began her work on understanding neurological diseases at the University of Minnesota, where she received her Ph.D. in Neuroscience.
Agenda Sessions
Antisense Oligonucleotides for the Treatment of Neurological Disease
, 9:30amView Session